Skip to main content
TRT
PROVIDER
GUIDE
RESOURCE

Does TRT Work? Yes, for a Few Things. Here's Exactly Which Ones

Last updated: October 1, 2026

Last verified: October 2026 · By the TRT Provider Guide Editorial Team · Editorial research, not clinically reviewed · Educational information, not medical advice

Does TRT work? Yes, for some outcomes in men with symptoms or signs plus consistently low testosterone confirmed with appropriate repeat early-morning testing. In the biggest trials, testosterone replacement therapy (TRT) improved sex drive and corrected anemia more often than placebo, and it produced small average improvements in mood and energy. It did not reliably improve erections, cognition, diabetes prevention or fracture risk. If you do not have confirmed testosterone deficiency, the evidence for benefit is much weaker.

That's the short version. The longer version matters because of one thing most TRT pages never show you: the placebo results. In these trials, men who got a fake gel often felt better too. Once you see how much, you'll read every "life-changing results" claim differently. We'll get there in a minute.

TRT is most likely to help you if:

  • Two morning blood tests confirmed your testosterone is low, and you have symptoms
  • Low sex drive is one of your main complaints
  • You have unexplained anemia (a low red blood cell count)
  • You'd welcome a small lift in mood

TRT is least likely to help you if:

  • Your testosterone is normal when tested correctly
  • Your only complaint is feeling tired
  • Erectile problems are your only complaint
  • You want weight loss or diabetes prevention without changing diet and exercise
  • You're trying to have a baby soon (TRT can lower sperm counts)

TRT Provider Guide is the independent decision resource for testosterone replacement therapy — helping U.S. adults understand how low testosterone is evaluated, compare online and local care models and providers, and choose the next step that fits their health needs, fertility plans, budget, state, and care preferences, with every material claim verified and dated.

Jump to what you want TRT to fix: Sex drive and erections · Energy, mood and brain fog · Weight, muscle and diabetes · Heart safety · How long it takes · I'm already on TRT and don't feel different

Does TRT work? The short answer by symptom

In men with confirmed low testosterone, TRT works best for sex drive and anemia and gives a small boost to mood. It works poorly or not at all for tiredness on its own, erections, walking ability, memory, diabetes prevention and bone fractures. The single biggest factor is whether your testosterone was truly low to begin with.

We sorted every major outcome from the large placebo-controlled trials into four plain labels. This is the whole answer on one screen.

Table 1: What you want TRT to do; Our verdict; What the best trial found
What you want TRT to do Our verdict What the best trial found
Raise sex drive Works Beat placebo; lasted 2 years (TRAVERSE)
Raise sexual activity Works, modestly About half an extra sexual activity per day vs placebo (TRAVERSE)
Fix a low red blood cell count (anemia) Works Corrected in 45% on TRT vs 34% on placebo at 12 months (TRAVERSE)
Lift mood Small effect Modest improvement, not a treatment for clinical depression (TRAVERSE)
More energy Small effect at best Main energy trial found no benefit; a larger trial found a modest one
Better erections Not reliable No difference vs placebo in the largest trial (TRAVERSE)
Walk farther, move better Not reliable Not significantly better than placebo (Testosterone Trials)
Sharper memory or focus Not shown No cognitive benefit found; doctors' guidelines advise against using TRT for this
Prevent diabetes Not on its own No difference vs placebo (TRAVERSE); helped only alongside a weight-loss program (T4DM)
Fewer broken bones No, the opposite More fractures on TRT than placebo (TRAVERSE)
Protect your heart No proven protection Major cardiovascular events were similar in TRAVERSE, but pulmonary embolism, atrial fibrillation and acute kidney injury were more common with testosterone

Sources and full numbers are in the next sections. "TRAVERSE" is a 5,246-man trial published in 2023–2024. The "Testosterone Trials" are a 790-man set of trials in men 65 and older. T4DM is a 1,007-man trial from Australia.

What does "working" actually mean?

"Working" can mean four different things with TRT: your testosterone number goes up, a symptom gets better, a health marker improves, or a real-world health event happens less often. TRT reliably does the first one. The other three depend on the symptom, and that gap is where most disappointment comes from.

Here's the trap. A clinic can raise your testosterone to a great number and truthfully say "your TRT is working." But you didn't start TRT to get a number. You started it to feel or function differently.

Table 2: Level of "working"; Example; How reliably TRT delivers it
Level of "working" Example How reliably TRT delivers it
1. The number rises Total testosterone goes from low to normal Very reliably, if the dose and product are right
2. A symptom improves Sex drive comes back Depends on the symptom (see table above)
3. A health marker improves Bone density or hemoglobin goes up Often yes
4. A real health event changes Fewer fractures, fewer heart attacks Not shown. Fractures were more common on testosterone; major cardiovascular events were similar between groups in TRAVERSE

Level 3 and level 4 can split apart. TRT can raise bone density on a scan and still fail to prevent broken bones. That happened in the largest trial ever run, and we'll show you the numbers below.

The takeaway: a better lab number is not proof your symptom was caused by low testosterone. Judge TRT by the thing you actually wanted fixed.

Does TRT work better than a placebo?

Yes for some outcomes, no for others. In large trials, men on placebo often improved too, so the treatment effect is the gap between the groups. By that test, TRT beat placebo for sex drive, sexual activity and anemia, produced small average gains in mood and energy in TRAVERSE, and did not show a reliable benefit for erections, cognition, diabetes prevention or fractures. Pulmonary embolism, atrial fibrillation, acute kidney injury and clinical fractures were more common in the testosterone group in TRAVERSE.

A placebo is a look-alike treatment with no active drug. In a good trial, neither the men nor their doctors know who got which. Both groups often improve, because people expect to feel better, because symptoms naturally go up and down, and because being in a study makes you pay attention to your health.

So the honest question isn't "did men on TRT get better?" It's "did they get better more than the men on placebo?"

Almost no TRT page shows you the placebo column. Here it is.

The Placebo-Column Scorecard

Table 3: Outcome; Trial; On testosterone; On placebo; What the gap tells you
Outcome Trial On testosterone On placebo What the gap tells you
Sexual activity (men with low sex drive) TRAVERSE, 1,161 men, 2 years Improved more: about 0.5 more sexual activities per day at 6 and 12 months Improved less Real, modest benefit that lasted to 24 months
Sex drive TRAVERSE Improved more Improved less Real benefit
Erections TRAVERSE No significant difference — No proven benefit
Anemia corrected at 6 months TRAVERSE, 815 men with anemia 41.0% 27.5% Real benefit. But note that 1 in 4 placebo men improved too
Anemia corrected at 12 months TRAVERSE 45.0% 33.9% Real benefit
Walked 50+ meters farther Testosterone Trials, men 65+ 20.3% 12.1% Not a significant difference in its own trial
Energy (main vitality test) Testosterone Trials No significant benefit — No proven benefit on the main measure
Mood and energy TRAVERSE, 5,204 men Modest improvement Less improvement Small real benefit
Prediabetes turning into diabetes by 4 years TRAVERSE, 1,175 men 13.4% 15.7% No significant difference
Any broken bone TRAVERSE, median 3.2 years 3.50% 2.46% Worse on TRT
Heart attack, stroke or cardiovascular death TRAVERSE, mean follow-up 33 months 7.0% 7.3% Primary MACE was noninferior to placebo; this does not prove heart protection or zero cardiovascular harm
Blood clot in the lung TRAVERSE 0.9% 0.5% Worse on TRT
Atrial fibrillation (irregular heartbeat) TRAVERSE 3.5% 2.4% Worse on TRT
Sudden kidney injury TRAVERSE 2.3% 1.5% Worse on TRT
High-grade prostate cancer TRAVERSE 0.5% 0.4% No significant difference over the trial's length

Sources: Lincoff et al., New England Journal of Medicine, 2023 (heart and safety results); Pencina et al., Journal of Clinical Endocrinology & Metabolism, 2024 (sexual function); Pencina et al., JAMA Network Open, 2023 (anemia); Bhasin et al., Journal of Clinical Endocrinology & Metabolism, 2024 (mood); Bhasin et al., JAMA Internal Medicine, 2024 (diabetes); Snyder et al., New England Journal of Medicine, 2024 (fractures); Snyder et al., New England Journal of Medicine, 2016 (Testosterone Trials).

What does "half an extra sexual activity per day" mean? TRAVERSE measured sex life with a daily 12-question diary covering sexual activity. On average, men on testosterone checked off about half an item more per day than men on placebo. That's real. It's also modest. Nobody's life got rebuilt by half a checkbox. But for a man whose sex drive had quietly disappeared, it can be the difference he notices first.

Why "96% of patients felt better" can't answer this question

You'll see big satisfaction numbers on clinic websites. For example, when checked October 1, 2026, Male Excel's homepage said 96% of its patients experience "life-changing results in six months." Its footnote said the figure came from 32,795 members responding to symptom reviews with their Male Excel providers. That is a provider-reported satisfaction/outcome claim, not a randomized comparison.

We're not saying those men didn't feel better. We're saying a survey like this has no placebo group. It's also collected by the company providing the treatment. Look back at the anemia row: about one in three men on a fake gel "got better" too. A clinic survey can't separate TRT's effect from hope, attention and time. Only a placebo comparison can.

That's why this page leans on trials, not testimonials.

What TRT did that nobody hoped for

TRAVERSE, the largest cardiovascular-safety trial of TRT, was designed to answer one scary question: did testosterone increase major cardiovascular events compared with placebo in men with hypogonadism who already had cardiovascular disease or high cardiovascular risk? For the trial's primary endpoint, it did not: testosterone was noninferior to placebo. That was genuinely important evidence, but it was not a finding of zero cardiovascular harm.

But the trial found some things nobody expected:

  • More broken bones. 3.50% of men on TRT had a fracture vs 2.46% on placebo. The researchers wrote that they did not expect this.
  • More blood clots in the lungs. 0.9% vs 0.5%. The Endocrine Society's July 2026 statement describes this as roughly a 50% relative increase.
  • More atrial fibrillation and sudden kidney injury.
  • No protection against diabetes in men with prediabetes.

The Endocrine Society, the world's largest organization of hormone doctors, said in July 2026 that long-term safety, including for prostate cancer, "remains unestablished."

None of this means TRT is dangerous for everyone. It means TRT is a specific treatment for a specific problem. It isn't a general health upgrade.

Does TRT work if your testosterone is normal?

The evidence is much weaker when testosterone deficiency has not been established. A 2024 Cochrane review of 43 randomized trials in men with sexual dysfunction excluded men with primary or secondary hypogonadism and found that testosterone probably makes little to no clinically important difference to erectile function or sexual quality of life in the short term. Major U.S. guidance ties a diagnosis of testosterone deficiency to low levels plus symptoms or signs.

This might be the most important section on the page. If testosterone deficiency has not been established, you are outside the population for whom TRT has the clearest evidence-based indication, while treatment risks and monitoring burdens still matter.

The Cochrane review is one of the most rigorous types of evidence summary in medicine. It pooled 43 studies with 11,419 men aged 40 and up who had sexual problems. It specifically left out men with diagnosed hypogonadism. Hypogonadism is the medical name for the testes not making enough testosterone, whether from a problem in the testes or in the brain signals that control them. For this population with sexual dysfunction but without primary or secondary hypogonadism, TRT probably had little to no clinically important effect on erections or sexual quality of life over the short term.

How low testosterone is supposed to be confirmed

Two of the main U.S. medical groups agree on the basics:

  • The American Urological Association (AUA) calls a total testosterone below 300 ng/dL a "reasonable cut-off" to support a diagnosis. Its strongest-graded rule is that the diagnosis should be made only after two total testosterone tests on separate days, both taken early in the morning. It also requires symptoms or signs, not just a number.
  • The Endocrine Society says diagnosis needs symptoms plus consistently low, accurately measured testosterone. In July 2026, it stressed that symptoms alone are not diagnostic. Low energy, low sex drive and low mood have many causes in men. Doctors should first look for reversible causes like obesity, opioid pain medicines or steroid medicines.

A few terms you'll see on lab reports:

  • Total testosterone: all the testosterone in your blood.
  • Free testosterone: the small part that isn't attached to proteins and is ready to use.
  • SHBG (sex hormone-binding globulin): the main protein testosterone attaches to. High or low SHBG can make total testosterone misleading.
  • LH (luteinizing hormone): the signal from your brain telling your testes to make testosterone. It helps show where the problem is.

Why your first number might be wrong

  • Time of day. Testosterone runs higher in the morning. An afternoon test can read low.
  • One test is one snapshot. Illness, bad sleep or a rough week can pull it down temporarily.
  • Labs don't all agree. The Endocrine Society warned in July 2026 that many testosterone tests aren't standardized, so the same blood sample can read "low" at one lab and "normal" at another. It recommends labs certified by the CDC's Hormone Standardization Program (HoST).
  • Your weight. For men whose low testosterone is tied to being overweight (BMI over 27) with no other cause found, the Endocrine Society says weight loss is typically the first treatment to try.

If your first result was borderline, repeat early-morning testing with an accurate assay is part of determining whether testosterone deficiency is actually present. A number alone still does not decide whether TRT is appropriate; symptoms, signs, the cause of a low result, health history and fertility plans also matter.

The right TRT provider is not the same for every person — it depends on whether low testosterone has been properly evaluated, your symptoms and health history, your fertility plans, your state, your insurance or cash-pay preference, your treatment-format preference, your budget, and whether online or in-person care is the better starting point. Some situations belong with primary care, urology, endocrinology, reproductive urology, or urgent or emergency care when the symptoms warrant it. Because a general answer cannot resolve those for you, use TRT Provider Guide's Find My TRT Path tool to map your situation to the right care route and the questions to ask before you pay.

Which group are you in? Answer a few questions about your testing, symptoms, fertility plans and state. You'll get an action plan: re-test, see a specialist, or start with a program, plus the questions to ask before you pay. It's educational, not a diagnosis.

Map the care route that fits your situation →

Were men like you in the TRT trials?

The strongest modern placebo-controlled evidence does not cover every person, product or care model. TRAVERSE studied men aged 45 to 80 with symptoms, two fasting morning testosterone results below 300 ng/dL, and cardiovascular disease or high cardiovascular risk using FDA-approved 1.62% testosterone gel. The Testosterone Trials studied men 65 and older using testosterone gel, while T4DM studied a different population using long-acting testosterone undecanoate injections.

A trial's results apply best to people like the ones it studied. So here's who was actually in the big three.

Table 4: TRAVERSE; Testosterone Trials; T4DM
TRAVERSE Testosterone Trials T4DM
Age 45–80 65 and older (average 72) 50–74
How low T was confirmed Two fasting morning tests below 300 ng/dL, at least 48 hours apart Average below 275 ng/dL 14 nmol/L (about 400 ng/dL) or lower, with no known disease of the testes or pituitary
Health profile Heart disease or high heart risk Many had obesity or diabetes Large waist plus prediabetes or new diabetes, all in a weight-loss program
Testosterone product AndroGel 1.62%, an FDA-approved gel Testosterone gel Testosterone undecanoate injection
Time on treatment About 2 years, with ~33 months of follow-up 1 year 2 years

Two details jump out.

First, the Testosterone Trials were picky. More than 51,000 men were screened, and only 790 made it in. Most men who think they have low testosterone didn't qualify.

Second, age may matter. In TRAVERSE's sexual-function study, the extra boost in sexual activity showed up in men over 65 but not in men under 65, based on a pre-planned subgroup analysis. Subgroup results are less certain than the main result, so treat this as a signal, not a rule.

What that means for you: trial results travel best to people and treatment conditions similar to those studied. They should not be treated as proof that every testosterone formulation, prescribing model or patient population will produce the same benefits or risks. Your clinician should judge response against the reason treatment was started, follow-up laboratory results and any adverse effects.

Does TRT work for sex drive and erections?

TRT works for sex drive better than for erections. In the 1,161-man TRAVERSE sexual-function study, testosterone improved sexual activity, sexual desire and low-testosterone symptoms for two years, but it did not significantly improve erectile function compared with placebo.

This is where TRT is strongest, and where expectations most often go wrong.

Sex drive: This is TRT's best-proven benefit. In TRAVERSE, men with low libido on testosterone had more sexual activity and more desire than men on placebo, and the effect held at two years. In the Testosterone Trials (men 65+), sex drive and sexual activity also improved.

Erections: Not reliably. TRAVERSE found no significant difference from placebo. The Testosterone Trials found a small improvement. For men without low testosterone, the Cochrane review found little to no effect.

Here's the frustrating combination some men end up with: more desire, same erections. That does not necessarily mean testosterone failed to raise hormone levels. It means erectile function depends on more than testosterone, including vascular, neurologic, medication-related and psychological factors.

If erections are your main problem: ED medications are a separate treatment and work differently. A clinician can also check for things ED can be an early warning of, like heart disease or diabetes. TRT alone is the wrong first move.

Does TRT work for energy, mood, depression and brain fog?

The effects here are small. TRAVERSE found modest improvements in mood and energy in men with low testosterone, but no improvement in memory, thinking or sleep quality, and no benefit in men with major depression. The American College of Physicians advises against starting TRT to improve energy or thinking in men with age-related low testosterone.

This is where TRT advertising runs furthest ahead of the evidence. "More energy" and "brain fog" are two of the most-advertised promises. They're also two of the least-proven.

Energy: The Testosterone Trials ran a dedicated vitality trial in men with low testosterone and fatigue. On its main measure, testosterone didn't beat placebo. Later, the larger TRAVERSE trial found a modest improvement in energy. Our honest read: a small lift is possible, but don't count on TRT to fix tiredness. The American College of Physicians (ACP) reviewed 38 randomized trials in 2020. It suggests doctors not start TRT to improve energy, vitality, physical function or thinking in men with age-related low testosterone.

Mood: In TRAVERSE, just over half the men (50.8%) had significant depressive symptoms at the start. That's a striking number on its own. Testosterone gave a modest improvement in mood compared with placebo.

Depression: In TRAVERSE, the rigorously defined persistent-depressive-disorder subgroup was very small and the study was underpowered for that subgroup; men with more severe depressive symptoms did not show the same benefit seen in men with milder symptoms. TRT is not a depression treatment. If low mood is weighing on you, that deserves care on its own terms, from your doctor or a mental health professional.

Brain fog and memory: TRAVERSE found no improvement in thinking skills. The ACP guideline advises against starting TRT for cognition.

If your fatigue or low mood has another cause, such as sleep apnea, depression, a thyroid problem, heavy drinking or simply not enough sleep, raising your testosterone may not touch it.

Does TRT help with weight loss, muscle or diabetes?

TRT shifts body composition slowly, adding some lean mass and trimming some fat over months, but it isn't a weight-loss drug. On its own, it didn't slow prediabetes turning into diabetes in TRAVERSE. In the T4DM trial, it helped only when added to a structured lifestyle program.

Muscle: In men with low testosterone, TRT can increase lean mass. According to a well-known review of treatment timelines, changes in fat, lean mass and strength start around 12 to 16 weeks and level off at 6 to 12 months. But more lean mass on a scan isn't the same as walking farther or lifting more. In the Testosterone Trials, the physical function trial's main walking test wasn't significantly better than placebo. And medical TRT restores normal levels. It's not a bodybuilding program, and the trials didn't test performance doses.

Weight and belly fat: TRT is not a weight-loss drug. For men whose low testosterone comes with being overweight and no other cause, the Endocrine Society says weight loss is typically first-line. Losing weight can raise testosterone on its own.

Diabetes: Two trials, two different answers, and the difference is the lesson.

  • TRAVERSE (testosterone alone): 13.4% of men with prediabetes progressed to diabetes on TRT vs 15.7% on placebo by four years. That's not a significant difference. The researchers concluded TRT alone shouldn't be used to prevent or treat diabetes.
  • T4DM (testosterone plus a weight-loss program): After two years, 12% of men on testosterone had type 2 diabetes vs 21% on placebo. But every man was in a lifestyle program, and none had a known disease of the testes or pituitary. The researchers themselves called it premature to treat these men with testosterone, and red blood cell counts rose on TRT.

Our read: TRT should not be used as a substitute for evidence-based weight or diabetes care. T4DM tested testosterone as an addition to a structured lifestyle program in a specific population; that result does not establish TRT as a general diabetes-prevention or weight-loss treatment.

Does TRT help anemia and bone health?

Anemia is one of TRT's clearest benefits: in TRAVERSE, 45% of men with anemia on testosterone had it corrected at 12 months vs 34% on placebo. But higher bone density hasn't turned into fewer fractures. TRAVERSE found more fractures on testosterone, not fewer.

Anemia: About 15% of older men with low testosterone have anemia, meaning too few red blood cells, which can cause tiredness and shortness of breath. In TRAVERSE, testosterone corrected anemia more often than placebo at every check from 6 to 48 months. It also made new anemia less likely in men who didn't have it. The researchers linked rising hemoglobin to better energy scores, which may explain some of the energy gains men report.

That same effect has a flip side. Testosterone can push red blood cells too high. That's why your hematocrit, the share of your blood made of red blood cells, gets checked while you're on TRT.

Bones: This is the clearest example of "a better number, a worse outcome." Earlier studies showed testosterone improves bone density and bone structure. So researchers expected fewer fractures. Instead, TRAVERSE found 3.50% of men on TRT had a clinical fracture vs 2.46% on placebo, over a median of about three years. The trial's chair said men with osteoporosis probably shouldn't take testosterone to reduce fracture risk.

Our read: Don't start TRT to protect your bones. If bone health is a concern, ask about treatments proven to prevent fractures.

Is TRT safe for your heart?

In TRAVERSE, the primary major-cardiovascular-event endpoint occurred in 7.0% of men on testosterone and 7.3% on placebo over a mean follow-up of 33 months. Testosterone met the trial's noninferiority criterion for that endpoint in men with hypogonadism and preexisting or high cardiovascular risk. That is not proof of heart protection or zero cardiovascular harm: pulmonary embolism, atrial fibrillation and acute kidney injury were more common in the testosterone group, and current FDA labeling includes blood-pressure warnings.

TRAVERSE was the trial the FDA asked for after years of worry that testosterone caused heart attacks. It was a noninferiority trial. That's a fancy way of saying it was built to answer "is testosterone not worse than placebo?" The trial met its prespecified noninferiority criterion for major cardiovascular events over the follow-up period.

That's a safety result. It isn't evidence that TRT protects your heart.

What still needs watching:

  • Blood pressure. In February 2025, the FDA added a class-wide warning about increased blood pressure on testosterone products, based on blood-pressure studies.
  • Blood clots. More clots in the lungs on TRT (0.9% vs 0.5%).
  • Irregular heartbeat. More atrial fibrillation (3.5% vs 2.4%).

One thing to know about the trial design: TRAVERSE used a daily FDA-approved gel, and it followed men for a few years, not decades. It doesn't tell us about every product or every dose.

How long does TRT take to work?

There is no universal TRT timeline. A 2011 review estimated that some sexual-interest effects can appear within weeks and body-composition or bone changes take longer, but most studies it summarized were not designed specifically to measure onset. A more useful checkpoint is the AUA's guidance to discuss stopping after 3 to 6 months when testosterone has normalized but symptoms or signs have not improved.

The timing estimates below come from a 2011 review that assembled studies published through that era. The authors themselves noted that almost none of the underlying studies were specifically designed to measure onset, so these are rough group-level estimates rather than a clock for any one person.

Table 5: When; What tends to show up (group averages); What your clinician should be checking
When What tends to show up (group averages) What your clinician should be checking
Weeks 3–6 Sex drive starts improving around week 3 and usually levels off by week 6. Quality of life improves at 3–4 weeks. Mood changes appear at 3–6 weeks. Whether your early symptoms are moving at all
Around month 3 Red blood cells start rising (peak at 9–12 months). Fat, lean mass and strength begin changing (12–16 weeks). A follow-up testosterone level to confirm you've reached the target range. Your hematocrit
Months 3–6 Erections may need up to 6 months. Mood keeps improving until about 18–30 weeks. The AUA's checkpoint: if your testosterone is normal but your symptoms haven't improved, discuss stopping
Month 6 Bone changes become measurable and keep going for at least 3 years Testosterone level (the AUA says every 6–12 months while on TRT), hematocrit, and prostate checks as your clinician advises
Month 12 Body composition changes settle at 6–12 months The ACP's checkpoint: re-evaluate within 12 months, and stop if sexual function hasn't improved (for age-related low testosterone)

Notice something? The most advertised promises, energy and fat loss, are among the least reliable outcomes. A calendar alone cannot tell you whether TRT is working. The better test is whether the original symptom or clinical target is improving while follow-up testing shows an appropriate treatment response.

Your 90-day TRT check-in sheet

Pick your top two or three goals. Rate each from 0 (terrible) to 10 (great) before you start, then at each check-in. Bring it to your follow-up visit. Honest numbers beat a vague "I guess I feel a bit better?"

Table 6: Goal; Before starting; Week 3; Week 6; Week 9; Week 12
Goal Before starting Week 3 Week 6 Week 9 Week 12
Sex drive
Morning erections
Mood
Energy
Sleep
Workouts / strength

Questions to bring at week 12:

  1. Is my testosterone now in the target range, and when in my dosing cycle was it measured?
  2. What's my hematocrit, and is it where it should be?
  3. Which of my goals has moved, and which hasn't? Is the one that hasn't moved something TRT is known to help?
  4. If a goal hasn't moved, what else could be causing it?
  5. What's our plan if I'm not clearly better by month 6?

Want this tracked for you? Our free check-in tracker lets you log your scores each week, shows them next to the typical timeline for each goal, and builds a one-page summary to bring to your follow-up. It stays on your device and doesn't diagnose anything.

Open the free 90-day TRT check-in tracker →

Why isn't my TRT working?

If TRT has raised testosterone but you do not feel better, the original symptom may have another cause, the treatment response may need clinical review, or the goal may be something TRT does not reliably improve. The AUA says clinicians should discuss stopping testosterone 3 to 6 months after starting when total testosterone has normalized but symptoms or signs have not improved.

If you're here because you're a couple of months in and don't feel much different, you're not alone. Here are the six most common reasons, roughly in order of how often they're worth checking.

  1. The goal may need more time — or may not be a reliable TRT outcome. Different outcomes were measured on different schedules, and exact week-by-week promises are not well established.
  2. The treatment response needs clinical review. Follow-up testosterone results have to be interpreted in the context of the product used and the timing of the blood draw.
  3. The measurements may not be directly comparable. Different laboratories, assays and collection methods can complicate comparisons.
  4. Something else may be causing the symptom. Sleep apnea, obesity, depression, thyroid disease, alcohol use, certain medicines and inadequate sleep can overlap with symptoms commonly blamed on low testosterone.
  5. Your goal may be one TRT does not reliably fix. Erectile dysfunction, fatigue, cognition and weight loss are all weaker or more variable outcomes than the marketing often suggests.
  6. The original diagnosis may need another look. One isolated result or testing outside the recommended diagnostic process is not enough by itself to establish testosterone deficiency.

When to push on and when to call it

The guidelines give you two clear checkpoints:

  • At 3 to 6 months: the AUA says clinicians should discuss stopping TRT if your testosterone has reached normal levels but your symptoms or signs haven't improved.
  • Within 12 months: the ACP says to re-evaluate, and to stop if sexual function hasn't improved (for age-related low testosterone).

Don't change your dose, skip doses or stop on your own. Testosterone is a prescription medicine, and stopping affects your hormones for a while. Make that decision with your prescriber.

Get emergency care right away for chest pain, sudden shortness of breath, coughing up blood, swelling or pain in one leg, sudden weakness or numbness on one side, trouble speaking, or a sudden severe headache. Call 911. These can be signs of a blood clot, heart attack or stroke.

Does TRT affect fertility?

Yes. Exogenous testosterone can suppress sperm production, sometimes profoundly, because it reduces the brain signals that support sperm production in the testes. Recovery after stopping often occurs but is not guaranteed on a set timeline. If near-term fertility matters, discuss that before TRT with a urologist, reproductive urologist, endocrinologist or other fertility-aware clinician.

This surprises many men, and some websites get it backwards. Some say TRT boosts sperm count. For testosterone therapy itself, the opposite is true.

Here's why. Your testes need two things to make sperm: brain signals (LH and a related hormone called FSH) and high testosterone levels inside the testes. When testosterone comes from outside, your brain senses plenty and turns those signals down. Blood testosterone goes up. Sperm production (called spermatogenesis) goes down.

How far down? A classic World Health Organization study in 1990 tested weekly testosterone shots as a possible male birth control in 271 healthy men. By six months, 65% had no sperm at all. After stopping, it took a median of about 3.7 months to recover normal counts. That study used a dosing schedule designed to stop sperm, not a typical TRT plan. But it shows how powerfully testosterone can shut sperm production down.

Recovery isn't guaranteed. In a 2017 study of 66 men who became infertile after using testosterone, 70% reached a basic sperm-count goal within 12 months of stopping and getting fertility treatment. Older men and men who'd used testosterone longer recovered more slowly.

If a baby is in your near-term plans: do not treat a general online TRT program as the default starting point. A urologist, reproductive urologist, endocrinologist or other fertility-aware clinician can evaluate the cause of low testosterone and discuss options. Clomiphene, enclomiphene and hCG are not TRT; their approval status, evidence, risks and role differ, so they need their own clinical evaluation.

What changed for TRT in 2025 and 2026?

In February 2025, the FDA removed heart-attack-and-stroke language from the boxed warning on testosterone products and added a blood-pressure warning. In June 2026, it asked manufacturers to drop a limitation for age-related low testosterone and to narrow prostate warnings. Medical groups still say diagnosis comes first and long-term safety isn't fully established.

TRT has been in the news a lot. Here's what actually happened, in order.

Table 7: Date; What happened
Date What happened
June 2023 TRAVERSE: no increase in heart attacks or strokes on TRT. More blood clots, irregular heartbeats and kidney injuries
January 2024 TRAVERSE: more fractures on TRT than placebo
February 28, 2025 FDA: remove heart-risk language from the boxed warning on all testosterone products. Add a blood-pressure warning. Keep the "not established for age-related low testosterone" limitation for now
December 10, 2025 FDA expert panel discusses loosening TRT restrictions. Consumer group Public Citizen criticizes the panel's selection process and focus
April 16, 2026 FDA invites testosterone manufacturers to apply for a new use: low sex drive in men whose low testosterone has no known cause
June 18, 2026 FDA requests label updates: remove the age-related limitation, make TRT off-limits only for metastatic prostate cancer instead of any known or suspected prostate cancer, and soften enlarged-prostate warnings
July 16, 2026 Endocrine Society: accurate diagnosis first. TRAVERSE showed roughly a 50% relative increase in lung clots plus more fractures. Long-term safety is unestablished

What this means for "does TRT work": the June 2026 change is about who the label covers and how risks are described. It didn't come from a new trial showing new benefits. The FDA based it mainly on TRAVERSE's heart-safety results. The benefit picture on this page is the same one the FDA was looking at.

Label updates roll out product by product. Your prescription's current label is the one that applies to you, so ask your pharmacist or check the product's prescribing information.

Two access facts that haven't changed:

  • Testosterone is a Schedule III controlled substance. That's a federal category for drugs with medical use but some potential for misuse. You need a valid prescription.
  • Federal telemedicine prescribing flexibilities currently run through December 31, 2026. DEA says registered practitioners may prescribe Schedule II–V controlled medications by qualifying telemedicine encounters without a prior in-person medical evaluation when the federal requirements and applicable state law are met. State law and a clinician's licensing or practice rules can still change what is available to you.

Does online TRT work as well as seeing a doctor in person?

No large randomized trial establishes that online TRT is more or less effective than in-person care as a delivery model. The medical basics are the same: establish the diagnosis, use an appropriate prescribed product, monitor treatment response and adverse effects, and reassess whether the symptoms that justified treatment actually improve.

The testosterone doesn't know whether it was prescribed over video or across a desk. What changes outcomes is the care around it. A program that gives TRT its best chance to work should:

  1. Confirm the diagnosis with symptoms or signs plus appropriately repeated early-morning testosterone testing
  2. Look for the cause with additional evaluation when indicated; the AUA specifically recommends LH in patients with low testosterone
  3. Recheck testosterone after treatment starts at timing appropriate to the formulation
  4. Monitor hematocrit and other clinically appropriate safety measures
  5. Reassess symptoms and signs instead of treating the lab number as the only outcome
  6. Ask about fertility plans before prescribing exogenous testosterone

That's the backbone of how we evaluate programs. You can read the full method in How We Review TRT Providers.

Does compounded testosterone have the same evidence as FDA-approved testosterone?

No. FDA-approved testosterone products have been reviewed by the FDA for their approved use and manufacturing standards. Compounded testosterone preparations are not FDA-approved, and the large randomized trials discussed on this page tested specific FDA-approved testosterone products rather than establishing equivalence for compounded preparations. If a program offers compounded testosterone, ask exactly what product would be prescribed, why that formulation is being considered, and which pharmacy would dispense it.

If your low T is confirmed, what is the next step?

A confirmed low testosterone result does not automatically tell you which care route or treatment format is right. The next step is to review the cause, your symptoms, fertility plans, health history, treatment goals, product options and monitoring plan with an appropriate clinician. If you are still sorting out the care route, use TRT Provider Guide's Find My TRT Path tool as an educational question organizer, not as a diagnosis or eligibility decision.

If insurance coverage or an FDA-approved retail-pharmacy product matters to you, primary care, urology or endocrinology may be the simplest place to start. If fertility is central, reproductive urology or another fertility-aware specialist is the better starting point. If you are considering an online program, compare its diagnostic process, clinician access, product and pharmacy disclosure, monitoring, state availability, total cost and cancellation terms before you pay.

Not sure which care route fits your situation? Use TRT Provider Guide's Find My TRT Path tool to organize the questions that matter for your testing, fertility plans, budget, insurance and care preferences. It is educational and non-diagnostic; it does not determine whether you have low testosterone or whether a clinician will prescribe TRT.

Use Find My TRT Path →

How we checked this

We read the primary trial papers and guideline statements, recorded the testosterone and placebo results side by side, and captured provider claims from their live pages with dates. We keep verified facts, provider statements and our own conclusions separate, following How We Review TRT Providers. This page was not clinically reviewed.

  • Trials: TRAVERSE (main results and its sexual function, mood, anemia, diabetes and fracture studies), the Testosterone Trials, and T4DM, read from the published papers, abstracts and trial registry results.
  • Reviews and guidelines: the 2024 Cochrane review on TRT for sexual dysfunction, the American College of Physicians 2020 guideline, the AUA Testosterone Deficiency guideline, and the Endocrine Society's July 16, 2026 statement.
  • Regulation: FDA and HHS announcements from February 2025 through June 2026, and the federal telemedicine rule extension through December 31, 2026.
  • Commercial claims: We checked current provider pages only where a provider claim is used as an example of why company-reported outcomes are not the same as placebo-controlled evidence. No provider is recommended on this informational page.
  • Our conclusions: the verdict labels ("Works," "Small effect," "Not reliable") are our editorial judgments based on the cited evidence. They aren't a medical score.

We didn't test TRT ourselves, treat patients or run a trial. Where we couldn't confirm something, we said so. You can read our full method in How We Review TRT Providers. For more on what TRT is, see our TRT guide. For the broader numbers, see TRT statistics.

Frequently asked questions

Does TRT work right away?

No. Sex drive usually changes first, starting around 3 weeks and leveling off around 6 weeks. Mood follows over weeks to months. Erections can take up to 6 months, and body changes take 3 to 12 months.

Is TRT just a placebo?

Not entirely. In large trials, testosterone beat placebo for sex drive, sexual activity and anemia. But men on placebo improved too, so some of what people feel is expectation and time, not the testosterone.

Does TRT work for everyone?

No. It works best in men with confirmed low testosterone and specific symptoms, especially low sex drive. Even then, some symptoms respond and others don't.

What percentage of men feel better on TRT?

There's no reliable single number. Clinic surveys have no placebo group. Trials measured specific symptoms, and they found real but modest gains for some and none for others.

Does TRT work if my testosterone is borderline?

It's unclear, and that's exactly why retesting matters. Repeat an early-morning test at a lab that uses a standardized assay before deciding. Men without truly low testosterone showed little to no sexual benefit in the Cochrane review.

Does TRT help erectile dysfunction?

Not reliably. The largest trial found better sex drive but no significant improvement in erections compared with placebo. ED often needs its own treatment.

Does TRT help with depression?

It gave a modest mood boost in men with low testosterone, but it didn't improve depression in men with major depression. It isn't a replacement for depression care.

Does TRT help you lose weight?

Not by itself. It slowly shifts fat and lean mass over months. For weight-related low testosterone, the Endocrine Society says weight loss is typically the first treatment.

Does TRT build muscle?

It can add some lean mass over several months in men with low testosterone. Medical TRT restores normal levels. It isn't a bodybuilding program, and walking and strength tests didn't reliably improve in trials.

Is TRT bad for your heart?

In the largest trial, heart attacks, strokes and heart deaths were about equal on TRT and placebo over roughly three years. But blood clots in the lungs and irregular heartbeats were more common, and blood pressure needs monitoring.

Will TRT make me infertile?

It can lower sperm counts, sometimes to zero. Recovery after stopping is common but not guaranteed, and it can take months or longer. See a specialist first if you want children soon.

What happens if TRT raises my testosterone but I still feel the same?

That's the moment to review the original diagnosis, your goals and other possible causes with your prescriber. The AUA says to discuss stopping if you're not better after 3 to 6 months with normal levels.

Does TRT work better as shots or gel?

The ACP found similar effectiveness between injections and skin products, with injections costing much less. The main trials used gels or long-acting injections.

Do I have to stay on TRT forever?

Not necessarily. But the benefits fade after stopping, and your body's own production can take time to recover. Our Is TRT worth it? page covers the long-term commitment and cost.

This page is educational information, not medical advice. It doesn't diagnose low testosterone or tell you to start, stop or change any medication. For chest pain, sudden shortness of breath, one-sided weakness or leg swelling, call 911.

Still not sure which TRT care route fits you? Use our free Find My TRT Path tool.

Sources

Not sure which TRT route fits you?

Find My TRT Path